新闻

Hyphens Pharma: Obtains Exclusive Rights To Commercialise Metoject Subcutaneous Autoinjector Pen In Singapore, Malaysia, The Philippines & Vietnam.

12 Mar 2025 09:46

Metoject subcutaneous autoinjector pen administers methotrexate, a well-established first-line treatment for rheumatoid arthritis...

Attachments:

• Hyphens_Pharma_MR_-_Metoject.pdf

Source: ShareInvestor Express